[{"NetIncomeLoss_1_Q2_USD":-53582000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":168899000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":74863000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":75189000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":44293000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":53211000.0,"InventoryFinishedGoods_0_Q2_USD":223000.0,"OperatingCostsAndExpenses_2_Q2_USD":2071000.0,"OperatingCostsAndExpenses_1_Q2_USD":1138000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":196000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":639000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":89644000.0,"Depreciation_2_Q2_USD":464000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":9903000.0,"InventoryRawMaterialsAndSupplies_0_Q2_USD":1825000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":273502000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":34732000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":74180000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":36530000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":2833000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2060000.0,"InventoryValuationReserves_0_Q2_USD":600000.0,"AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear_0_Q2_Security":20.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":124376000.0,"CommonStockSharesIssued_0_Q2_shares":75334000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":96587000.0,"Assets_0_Q2_USD":286567000.0,"EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_0_Q2_USD":2140000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":96479000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-173000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":33981000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":9000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-155000.0,"InventoryWriteDown_1_Q2_USD":100000.0,"InventoryWriteDown_2_Q2_USD":245000.0,"AssetsFairValueDisclosure_0_Q2_USD":194855000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":375000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":436000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":283000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":134000.0,"CommonStockValue_0_Q2_USD":8000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":2006000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_2_Q2_USD":2588000.0,"ShareBasedCompensation_2_Q2_USD":15494000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":9000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":9000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1506000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-111318000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-53687000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2141000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":141309000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":10199000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1082220000.0,"Liabilities_0_Q2_USD":369699000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":2833000.0,"EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_1_Q2_USD":600000.0,"EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_2_Q2_USD":610000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-41000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":72736000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":71031000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":8665000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":53589000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":5006000.0,"CommonStockSharesOutstanding_0_Q2_shares":75334000.0,"MarketableSecuritiesGainLoss_2_Q2_USD":14000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-110713000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-53448000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":15494000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8135000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-149000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-64000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-108636000.0,"InventoryWorkInProcess_0_Q2_USD":1857000.0,"LiabilitiesCurrent_0_Q2_USD":58123000.0,"DeferredRevenueCurrent_0_Q2_USD":0.0,"AccountsPayableCurrent_0_Q2_USD":2309000.0,"NonoperatingIncomeExpense_2_Q2_USD":-9292000.0,"NonoperatingIncomeExpense_1_Q2_USD":-4400000.0,"InterestExpense_2_Q2_USD":10096000.0,"InterestExpense_1_Q2_USD":5001000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":142710000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":15058000.0,"PaymentsForRoyalties_2_Q2_USD":4068000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":44293000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"ReceivablesNetCurrent_0_Q2_USD":17887000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1755000.0,"NetIncomeLoss_2_Q2_USD":-110996000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1165556000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":386000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1148000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":5773000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":45861000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":22601000.0,"OperatingIncomeLoss_2_Q2_USD":-101421000.0,"OperatingIncomeLoss_1_Q2_USD":-49048000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":94581000.0,"InventoryNet_0_Q2_USD":3905000.0,"InvestmentIncomeInterest_2_Q2_USD":429000.0,"InvestmentIncomeInterest_1_Q2_USD":165000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":117000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":286567000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":8135000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2079000.0,"OperatingExpenses_2_Q2_USD":147282000.0,"OperatingExpenses_1_Q2_USD":71649000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":196000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":762000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.48,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.71,"ProfitLoss_2_Q2_USD":-110996000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":0.0,"OtherLiabilitiesCurrent_0_Q2_USD":524000.0,"StockholdersEquity_0_Q2_USD":-83132000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":15494000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-297000.0,"Ticker":"KPTI","CIK":"1503802","name":"KARYOPHARM THERAPEUTICS INC.","OfficialName":"Karyopharm Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"566245834.0","Country":"United States","Sector":"Miscellaneous","Industry":"Diversified Commercial Services","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]